Sign in
4

Changes in Ownership

Atrium Therapeutics, Inc. Filed Acc 0001193125-26-397936

Chief Strategy Officer gave up 8,320 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hoyos Rocio Martin Chief Strategy Officer 2026-09-18 Shares withheld for taxes −8,320 $8.95 $74,464 38,340 D
Loading xslF345X06/ownership.xml…